What is the minimum investment required for PCD Pharma Franchise?

The minimum investment typically ranges from ₹2–5 lakhs, depending on territory size, product selection and initial stock planning. Our team will help structure this based on your goals.

What documents are required to become a franchise partner?

You will need a valid Drug License, GST registration and basic KYC documents. Our team will guide you through every step of the documentation process.

What kind of support and training do you provide?

We provide product training, sales guidance, marketing materials, doctor coverage strategies, and ongoing business support through dedicated account managers.

How are territories allocated and protected?

Territories are allocated based on mutual agreement and market mapping. We offer genuine monopoly rights with clear documentation to avoid internal competition.

What is the expected profit margin and ROI timeline?

Average profit margins range from 25–30%, with typical ROI timelines between 12–18 months, depending on your execution and territory potential.

How do you ensure product quality and compliance?

All products are manufactured in WHO-GMP certified facilities with 100% quality testing, robust documentation and DCGI approvals as applicable.

What is the delivery timeline and process?

Dispatch timelines depend on order size and location, but we maintain a strong track record of timely delivery across India with proper packaging and logistics partners.

Vials

Zax-S 1.5

Ceftriaxone 1000mg+Sulbactam 500mg

Pack: SINGLE
Format: With Carton

MRP₹131.25

A powerful synergistic antibiotic injection formulated for the management of severe bacterial infections and the treatment of resistant pathogens. Zax-S 1.5 combines the third-generation cephalosporin, Ceftriaxone, with the potent beta-lactamase inhibitor, Sulbactam, to provide a comprehensive bactericidal effect.

About The Product

Key Benefits

Synergistic Antimicrobial Attack

Ceftriaxone 1000mg works by inhibiting the synthesis of the bacterial cell wall, leading to the rapid destruction of the pathogen. When combined with Sulbactam, its spectrum of activity is significantly expanded to include many resistant strains.

Overcoming Bacterial Resistance

Sulbactam 500mg acts as a protective shield for the antibiotic. It irreversibly binds to beta-lactamase enzymes produced by bacteria, preventing them from deactivating the Ceftriaxone and ensuring the medication remains potent.

Broad-Spectrum Clinical Coverage

The formulation is highly effective against a diverse range of Gram-positive and Gram-negative aerobic and anaerobic bacteria. This makes it an ideal choice for empiric therapy in serious infections where the specific pathogen is not yet identified.

Superior Tissue and CSF Penetration

Zax-S demonstrates excellent distribution into various body fluids and tissues. Its ability to achieve therapeutic levels in the cerebrospinal fluid makes it a critical tool for managing neurological and systemic infections.

Prevention of Treatment Failure

By neutralizing the primary defense mechanism of bacteria (beta-lactamase production), this combination reduces the risk of clinical relapse and treatment failure often seen with cephalosporin monotherapy.

Rapid Systemic Bioavailability

The injectable delivery ensures 100% absorption and immediate therapeutic plasma levels. This is essential for the management of acute, life-threatening conditions where time-to-treatment is a critical factor.

Indication Severe Septicemia, Complicated Urinary Tract Infections, Nosocomial Pneumonia and Respiratory Infections, Intra-abdominal Infections (Peritonitis), Pelvic Inflammatory Disease, Post-Surgical Prophylaxis.

Indications

Severe Septicemia
Complicated Urinary Tract Infections
Nosocomial Pneumonia and Respiratory Infections
Intra-abdominal Infections (Peritonitis)
Pelvic Inflammatory Disease
Post-Surgical Prophylaxis.

Product descriptions, dosage forms, and compositions listed on the website are for reference by licensed practitioners and distributors only.

Zax-S 1.5